- $6.89bn
- $7.89bn
- $3.09bn
- 89
- 46
- 96
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,838 | 2,171 | 2,247 | 2,785 | 3,092 |
Cost of Revenue | |||||
Gross Profit | 808 | 661 | 594 | 724 | 911 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,596 | 2,592 | 2,505 | 2,592 | 2,757 |
Operating Profit | 242 | -421 | -258 | 193 | 335 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 190 | -461 | -291 | 165 | 294 |
Provision for Income Taxes | |||||
Net Income After Taxes | 143 | -272 | -247 | 123 | 223 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 142 | -273 | -247 | 122 | 223 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 142 | -273 | -247 | 122 | 223 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.29 | 1.54 | -0.487 | 1.98 | 3.66 |